Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1158780 · FYE Jun 30 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.58Day −5.95%Mkt cap $17M1Y −69.0%Off 52W high −72.2%Vol (1Y) 72.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,000 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.2% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.01% |
| Top-10 13F concentration99.3% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$1.1M |
| Earnings (TTM)-$25.5M |
| Net margin−1690.3% |
| Sales growth 3Y78.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−47.2% |
| 1Y−69.0% |
| 3Y−73.3% |
| Since incept. (ann.)−33.3% |
Total return through 2026-07-29 · series begins 2022-07-27. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)72.9% |
| Ann. volatility (3Y)79.3% |
| Sharpe (1Y)−1.35 |
| Sharpe (3Y)−0.19 |
| Max drawdown (1Y)−72.2% |
| Max drawdown (3Y)−80.6% |
| Beta (3Y vs SPY)1.39 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 19,424 | $65,946 | 0.19% | −3.0% |
| MORGAN STANLEY | 3,076 | $10,443 | 0.03% | −0.0% |
| EverSource Wealth Advisors, LLC | 2,000 | $6,790 | 0.02% | +0.0% |
| CITIGROUP INC | 1,360 | $4,610 | 0.01% | +6700.0% |
| SIMA Wealth Partners, LLC | 350 | $1,189 | 0.00% | +0.0% |
| WELLS FARGO & COMPANY/MN | 185 | $628 | 0.00% | +0.0% |
| JPMORGAN CHASE & CO | 125 | $420 | 0.00% | +0.0% |
| SBI Securities Co., Ltd. | 97 | $329 | 0.00% | +94.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.55 | — | $167,000 | −60.9% |
| 2025-12-31 | 2026-02-12 | −$0.71 | — | $198,000 | +7.0% |
| 2025-09-30 | 2025-11-12 | −$0.65 | — | $316,000 | −3.1% |
| 2025-06-30 | 2025-09-17 | — | — | $398,000 | +314.6% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
